🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

59,53 USD

Máx. histórico

2.925,00

12010 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,96%

Rango 52 semanas

37,06 – 95,49

Variación hoy

-0,07%

Cierre anterior

59,57

Rango de hoy

59,25 – 60,89

Volumen hoy

1.327.132

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,88%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 7 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
05/01/1995 40,95 40,95 40,95 40,95 +0,00% 0,00% 0
04/01/1995 40,95 40,95 40,95 40,95 -10,00% 0,00% 5
03/01/1995 45,50 45,50 45,50 45,50 +0,00% 0,00% 0
30/12/1994 40,95 122,20 40,95 45,50 +11,11% 198,41% 30
29/12/1994 40,95 40,95 40,95 40,95 -49,60% 0,00% 1
28/12/1994 81,25 81,25 81,25 81,25 +0,00% 0,00% 0
27/12/1994 81,25 81,25 81,25 81,25 +0,00% 0,00% 0
23/12/1994 81,25 81,25 81,25 81,25 +0,00% 0,00% 81
22/12/1994 81,25 101,40 81,25 81,25 +32,98% 24,80% 44
21/12/1994 61,10 61,10 61,10 61,10 -50,00% 0,00% 5
20/12/1994 81,25 122,20 40,95 122,20 +20,51% 100,00% 57
19/12/1994 122,20 122,20 81,25 101,40 +0,00% 33,51% 60
16/12/1994 122,20 122,20 101,40 101,40 -17,02% 17,02% 7
15/12/1994 101,40 122,20 101,40 122,20 +20,51% 20,51% 7
14/12/1994 101,40 101,40 101,40 101,40 -17,02% 0,00% 2
13/12/1994 122,20 122,20 122,20 122,20 -14,16% 0,00% 5
12/12/1994 142,35 162,50 142,35 142,35 -12,40% 14,16% 51
09/12/1994 142,35 162,50 142,35 162,50 -11,03% 14,16% 43
08/12/1994 182,65 182,65 182,65 182,65 +12,40% 0,00% 6
07/12/1994 203,45 243,75 162,50 162,50 -33,33% 39,94% 98
06/12/1994 243,75 243,75 243,75 243,75 +0,00% 0,00% 10
05/12/1994 243,75 243,75 243,75 243,75 +0,00% 0,00% 27
02/12/1994 243,75 243,75 243,75 243,75 -29,38% 0,00% 12
01/12/1994 325,00 345,15 325,00 345,15 +6,20% 6,20% 10
30/11/1994 406,25 406,25 325,00 325,00 -11,19% 20,00% 47
29/11/1994 345,15 487,50 345,15 365,95 +20,04% 41,24% 49
28/11/1994 325,00 365,95 304,85 304,85 -6,20% 18,80% 38
25/11/1994 325,00 325,00 325,00 325,00 +0,00% 0,00% 0
23/11/1994 325,00 325,00 325,00 325,00 +14,16% 0,00% 5
22/11/1994 284,70 284,70 284,70 284,70 +46,00% 0,00% 8